C#Cc1ccc([C@H]2C=C(C(=O)OCC=C)O[C@@H](OCC)[C@@H]2CCCO)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?